Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Phytochemicals As Modulators of Paraoxonase‐1 in Health and Diseases Publisher



Arab ZN1 ; Khayatan D1 ; Razavi SM1 ; Zare K2 ; Kheradkhah E1 ; Momtaz S3, 4, 5 ; Ferretti G6 ; Bacchetti T7 ; Sathyapalan T8 ; Emami SA9 ; Abdolghaffari AH1, 3, 4, 5 ; Sahebkar A10, 11, 12
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  2. 2. School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran
  3. 3. Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran
  4. 4. Department of Toxicology and Pharmacology, School of Pharmacy, and Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), the Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
  5. 5. GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  6. 6. Department of Clinical Science, Polytechnic University of Marche, Ancona, Italy
  7. 7. Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy
  8. 8. Department of Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, Hull, HU3 2JZ, United Kingdom
  9. 9. Department of Traditional Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  10. 10. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  11. 11. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  12. 12. Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Antioxidants Published:2022


Abstract

Chronic diseases such as cardiovascular disease (CVD), atherosclerosis, chronic liver disease, and neurodegenerative diseases are major causes of mortality. These diseases have gained much attention due to their complications, and therefore novel approaches with fewer side effects are an important research topic. Free radicals and oxidative stress are involved in the molecular mechanisms of several diseases. Antioxidants can scavenge free radicals and mitigate their adverse effects. One of the most important antioxidant enzymes are paraoxonases (PONs). These enzymes perform a wide range of physiological activities ranging from drug metabolism to detoxification of neuroleptics. Paraoxonase‐1 (PON1) is produced in the liver and then transferred to the bloodstream. It has been demonstrated that PON1 could have beneficial effects in numerous diseases such as atherosclerosis, CVD, diabetes mellitus, and neurodegenerative diseases by modulating relevant signalling pathways involved in inflammation and oxidative stress. These pathways include peroxisome proliferator‐activated receptor gamma (PPAR‐γ) and protein kinase B/nuclear factor kappa‐light‐chain‐enhancer of activated B cells (AKT/NF‐κB)‐dependent signalling pathways. Increasing PON1 could potentially have protective effects and reduce the incidence of various diseases by modulating these signalling pathways. Several studies have reported that dietary factors are able to modulate PON1 expression and activity. This review aimed at summarizing the state of the art on the effects of dietary phytochemicals on PON1 enzyme activity and the relevant signalling pathways in different diseases. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Other Related Docs
22. Antioxidant Genes, the Insecticide Diazinon, and Toxicity, Toxicology: Oxidative Stress and Dietary Antioxidants (2020)